Ombitasvir/Paritaprevir/Ritonavir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ombitasvir/Paritaprevir/Ritonavir, covering 2017-09-05 to 2017-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults [Phase 3]